Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index; none of the 6 sources its claims cite is checked for support yet.

The effect of nisin on the biofilm production, antimicrobial susceptibility and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa

Open access

Abstract

Objectives: Staphylococcus aureus and Pseudomonas aeruginosa were the most common bacteria in nosocomial infections. Different bacteriocins are currently being studied as antibiotics or in conjunction with antibiotics as potential strategies to treat resistant infectious agents. The study aimed to determine nisin's effect on the biofilm production, antimicrobial susceptibility, and biofilm formation of S. aureus and P. aeruginosa . Materials and methods: The experimental research tested two antibiotic-resistant isolates of S. aureus and P. aeruginosa strains. The experimental study tested two antibiotic-resistant isolates of S. aureus and P. aeruginosa strains. The MIC of bacteriocin nisin was determined using the micro broth dilution method, and crystal violet was used to assess the effect of bacteriocin on the biofilm. In addition, L929 cell culture was used to determine the effectiveness of bacteriocin on the isolate under similar cell conditions. Moreover, the MTT assay was used to and evaluate bacteriocin toxicity. In this study, the software Prism version 9 and Graph pad software were utilized. Results: The results of this study reveal that the nisin has different activities at different doses and is considered dose-dependent. At various times and doses, nisin inhibits biofilm formation in S. aureus , and P. aeruginosa isolates. Nisin also showed a decreasing survival of the isolates. Antibiotic-resistant bacteria can be made more vulnerable by nisin. Furthermore, nisin treatment affected the production of virulence factors such as hemolysins in S. aureus and had little or a negative effect on P. aeruginosa virulence factors. This medication stops S. aureus and P. aeruginosa from growing and causes bacterial cell damage. Conclusions: Antibacterial properties of nicin against S. aureus and P. aeruginosa were successfully studied. This bacteriocin stops S. aureus and P. aeruginosa from growing and causes bacterial cell damage or death. Damage to the membrane among the fundamental causes is reduced membrane potential and enzyme inactivation.

Overview

CoChat Summary

TL;DR

Nisin inhibited growth and biofilm formation/destruction of *S. aureus* and *P. aeruginosa* in an isolate- and dose/time-dependent manner, with MICs ranging from 2 µg/ml for *S. aureus* ATCC25923 to 256 µg/ml for MRSA SA-1, while PA-1 was resistant. It reduced *S. aureus* hemolysin, increased *P. aeruginosa* pyoverdine, left pyocyanin and LasB largely unchanged, and showed dose-dependent L929 toxicity with IC50 >256 µg/ml.

Key findings

  • MIC of nisin: SA-1 (MRSA) = 256 µg/ml; *S. aureus* ATCC25923 = 2 µg/ml; *P. aeruginosa* PAO1 = 64 µg/ml; PA-1 = resistant; co-culture SA-1/PA-1 = 128 µg/ml.
  • Nisin destroyed SA-1 biofilm after 24 and 48 h, but PA-1 biofilm only after 48 h; in co-culture, biofilm degradation occurred after 48 h, and biofilm production in simultaneous culture was less than in single culture. Nisin prevented SA-1 and PA-1 biofilm formation and disrupted established biofilm at its MIC.
  • Viability: SA-1 viable count increased over 24 and 48 h; PA-1 showed reduced viable count during the first 24 h; in co-culture SA-1/PA-1, none grew after nisin treatment. In L929 cell culture, PA-1 biofilm in co-culture decreased after 72 h, and SA-1 planktonic counts in co-culture decreased significantly after 72 h.
  • Virulence/toxicity: hemolysin of SA-1 decreased significantly after treatment; pyoverdine production in nisin-treated PA-1 planktonic state increased significantly (P < 0.05); pyocyanin and LasB were not affected. MTT toxicity was dose-dependent, and IC50 was >256 µg/ml.

Methods

  • Experimental in vitro study using clinical antibiotic-resistant isolates SA-1 (MRSA) and PA-1 (multidrug-resistant *P. aeruginosa*), plus control strains *S. aureus* ATCC25923 and *P. aeruginosa* PAO1; tested mono- and co-cultures.
  • MIC by microbroth dilution in 96-well plates using nisin stock at 512 µg/ml and serial dilutions from 256 to 0.025 µg/ml for 16 h at 37 °C; biofilm measured by crystal violet absorbance at 540 nm; growth/death and biofilm experiments over 24–48 h and 24–144 h.
  • L929 fibroblast cell culture used for planktonic/biofilm co-culture and MTT toxicity at nisin 0.25–256 µg/mL; virulence assays for hemolysin, pyocyanin, pyoverdine, and LasB protease; analysis with GraphPad Prism v9 using two-way ANOVA, one-way ANOVA, and t-tests, with data as mean ± SEM.

Limitations

  • The paper does not state a formal limitations section; in the discussion, the authors attribute cross-study discrepancies to type/quality of nisin, mutations in bacterial isolates, geographical differences, isolate type, and gene expression patterns (stated).
  • Evident: only one clinical MRSA isolate (SA-1) and one multidrug-resistant *P. aeruginosa* isolate (PA-1), plus control strains, were tested, so strain-specific findings may not generalize.
  • Evident: all experiments are in vitro and L929 cell-line based; no in vivo infection model is reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40001-022-00804-x

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 a Number of colonies of SA-1, PA-1, SA-1/PA-1 isolates in-vitro before and after treatment with nisin.SA-1: S. aureus isolate.PA-1: P. aeruginosa isolate. SA-1/PA-1 S. aureus isolated from co-culture. SA-1/PA-1 p: P. aeruginosa isolated from co-culture. b Distribution of biofilms of SA-1, PA-1, SA-1/PA-1 isolates before and after treatment with nisin
Fig. 1 a Number of colonies of SA-1, PA-1, SA-1/PA-1 isolates in-vitro before and after treatment with nisin.SA-1: S. aureus isolate.PA-1: P. aeruginosa isolate. SA-1/PA-1 S. aureus isolated from co-culture. SA-1/PA-1 p: P. aeruginosa isolated from co-culture. b Distribution of biofilms of SA-1, PA-1, SA-1/PA-1 isolates before and after treatment with nisinCC BY · PubMed Central
Fig. 2 Inhibition of biofilm production at various concentrations of nisin In the period 24–144 h for S. aureus (a), P. aeroginosa (b) and co-culture S. aureus and P. aeroginosa (c)
Fig. 2 Inhibition of biofilm production at various concentrations of nisin In the period 24–144 h for S. aureus (a), P. aeroginosa (b) and co-culture S. aureus and P. aeroginosa (c)CC BY · PubMed Central
Fig 3 a Number of colonies of PA-1, SA-1/PA-1p isolates in cell culture, before and after treatment with nisin.PA-1P: P. aeruginosa Planktonic. SA-1/PA-1 P: P. aeruginosa Planktonic isolated from co-culture. PA-1 B: P. aeruginosa biofilm. SA-1/PA-1p B: P. aeruginosa biofilm isolated from co-culture 3b: number of colonies of SA-1, SA-1/PA-1 s isolates in cell culture, before and after treatment with nisin. SA-1P: S. aureus Planktonic. SA-1/PA-1P s: S. aureus planktonic isolated from co-culture. SA-1 B: S. aureus biofilm. SA-1/PA-1 s B: S. aureus biofilm isolated from co-culture.
Fig 3 a Number of colonies of PA-1, SA-1/PA-1p isolates in cell culture, before and after treatment with nisin.PA-1P: P. aeruginosa Planktonic. SA-1/PA-1 P: P. aeruginosa Planktonic isolated from co-culture. PA-1 B: P. aeruginosa biofilm. SA-1/PA-1p B: P. aeruginosa biofilm isolated from co-culture 3b: number of colonies of SA-1, SA-1/PA-1 s isolates in cell culture, before and after treatment with nisin. SA-1P: S. aureus Planktonic. SA-1/PA-1P s: S. aureus planktonic isolated from co-culture. SA-1 B: S. aureus biofilm. SA-1/PA-1 s B: S. aureus biofilm isolated from co-culture.CC BY · PubMed Central
Fig. 4 Produced hemolysin by SA-1 and SA-1/PA-1 s before and after treatment with nisin. Wild type: non-treated S. aureus. SA-1 planktonic: treated S. aureus planktonic. SA-1 biofilm: treated S. aureus biofilm.SA-1/PA-1: non-treated S. aureus isolated from co-culture. SA-1/PA-1 biofilm: treated S. aureus biofilm isolated from co-culture. SA-1/PA-1 planktonic: treated S. aureus planktonic isolated from co-culture
Fig. 4 Produced hemolysin by SA-1 and SA-1/PA-1 s before and after treatment with nisin. Wild type: non-treated S. aureus. SA-1 planktonic: treated S. aureus planktonic. SA-1 biofilm: treated S. aureus biofilm.SA-1/PA-1: non-treated S. aureus isolated from co-culture. SA-1/PA-1 biofilm: treated S. aureus biofilm isolated from co-culture. SA-1/PA-1 planktonic: treated S. aureus planktonic isolated from co-cultureCC BY · PubMed Central
Fig. 5 a Pyoverdine output before and after treatment with nisin. PA-1: P. aeruginosa non Treated. PA-1B: P. aeruginosa biofilm. SA-1/PA-1pP: P. aeruginosa Planktonic Treated isolated from co-culture. SA-1/PA-1pB: P. aeruginosa biofilm treated isolated from co-culture. b Pyocyanin output before and after treatment with nisin. SA-1/PA-1pPt: P. aeruginosa planktonic treated isolated from co-culture. SA-1/PA-1pBt: P. aeruginosa biofilm treated isolated from co-culture. PA-1Pt: P. aeruginosa planktonic treated. PA-1Bt: P. aeruginosa biofilm treated.
Fig. 5 a Pyoverdine output before and after treatment with nisin. PA-1: P. aeruginosa non Treated. PA-1B: P. aeruginosa biofilm. SA-1/PA-1pP: P. aeruginosa Planktonic Treated isolated from co-culture. SA-1/PA-1pB: P. aeruginosa biofilm treated isolated from co-culture. b Pyocyanin output before and after treatment with nisin. SA-1/PA-1pPt: P. aeruginosa planktonic treated isolated from co-culture. SA-1/PA-1pBt: P. aeruginosa biofilm treated isolated from co-culture. PA-1Pt: P. aeruginosa planktonic treated. PA-1Bt: P. aeruginosa biofilm treated.CC BY · PubMed Central
Fig. 6 MTT test results show dose-dependent toxicity. Therefore, by increasing the dose of nisin, toxicity increases. As the data show, increasing the concentration of nisin increases the toxicity and IC50 nisin is more than 256 µ/ml
Fig. 6 MTT test results show dose-dependent toxicity. Therefore, by increasing the dose of nisin, toxicity increases. As the data show, increasing the concentration of nisin increases the toxicity and IC50 nisin is more than 256 µ/mlCC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 5 Not checked · 32 Own results and interpretations

21 more claims

Create a free account to see all 37 claims and to verify the 6 references still open.

See all claims — free account
  • It may state two separate claims as one. 9
  • Probably not a substantial claim. 5

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 25 references

Research works printed but not linked: 3

  1. Akoto CO, Acheampong A, Tagbor PD, Bortey K. Determination of the antimicrobial and antioxidant activities of the leaf extracts of Griffonia simplicifolia. J Pharmacogn Phytochem. 2020;9(2):537–45.
  2. El-Fouly M, Sharaf A, Shahin A, El-Bialy HA, Omara A. Biosynthesis of pyocyanin pigment by Pseudomonas aeruginosa. J Radiat Res Appl Sci. 2015;8(1):36–48.
  3. O’Toole GA. Microtiter dish biofilm formation assay. JoVE J Vis Exp. 2011;47: e2437.

Cited by

See all 38

Metadata

Authors
Ghapanvari, P., Taheri, M., Jalilian, F. A., Dehbashi, S., Dezfuli, A. A. Z., & Arabestani, M. R.
Affiliations
  • Hamedan University of Medical Sciences (IR)
  • Ahvaz Jundishapur University of Medical Sciences (IR)
Corresponding author
Arabestani, Mohammad Reza
Venue
European Journal of Medical Research
Published
2022-09-08
Volume
27
Issue
1
Pages
173-173
ISSN
  • 0949-2321 (ISSN-L)
  • 2047-783X
OpenAlex
W4295079793
Cited by
38
References
25
Citations by year
2026: 10 · 2025: 17 · 2024: 9 · 2023: 2
FWCI
1.93
Type
journal article
Language
en
Open access
Licence
Locations
  • European journal of medical research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
The vice chancellor for research and technology, Hamadan university of medical science (9811018469)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
Keywords
nisin, Staphylococcus aureus, Pseudomonas aeruginosa, biofilm formation, antimicrobial susceptibility, antibiotic resistance, bacteriocins, nosocomial infections, hemolysin, virulence factors, membrane damage
MeSH terms
Anti-Bacterial Agents, Bacteriocins, Humans, Microbial Sensitivity Tests, Nisin, Pseudomonas aeruginosa, Staphylococcal Infections, Staphylococcus aureus, Biofilms, Virulence Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of nisin on the biofilm production, antimicrobial susceptibility and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa. https://app.cochat.ai/papers/10.1186/s40001-022-00804-x
The paper
Ghapanvari, P., Taheri, M., Jalilian, F. A., Dehbashi, S., Dezfuli, A. A. Z., & Arabestani, M. R. (2022). The effect of nisin on the biofilm production, antimicrobial susceptibility and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa. European Journal of Medical Research. https://doi.org/10.1186/s40001-022-00804-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.